LOBEF (Lobe Sciences) FCF Margin %: 0.00% (As of Feb. 2026)


What is Lobe Sciences FCF Margin %?

Lobe Sciences LOBEF FCF Margin % is 0.00% as of Feb. 2026. The stock has 2 warning signs investors should review. Among 960 Biotechnology companies, Lobe Sciences ranks worse than 104166.56% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Lobe Sciences's Free Cash Flow for the three months ended in Feb. 2026 was $-1.51 Mil. Lobe Sciences's Revenue for the three months ended in Feb. 2026 was $0.00 Mil. Therefore, Lobe Sciences's FCF Margin % for the quarter that ended in Feb. 2026 was 0.00%.

As of today, Lobe Sciences's current FCF Yield % is -13.92%.

The historical rank and industry rank for Lobe Sciences's FCF Margin % or its related term are showing as below:


During the past 13 years, the highest FCF Margin % of Lobe Sciences was -204.40%. The lowest was -339.71%. And the median was -298.32%.

LOBEF's FCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -85.21
* Ranked among companies with meaningful FCF Margin % only.

Lobe Sciences FCF Margin % Related Terms

Lobe Sciences FCF Margin % Historical Data

* Premium members only.

The historical data trend for Lobe Sciences's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lobe Sciences FCF Margin % Chart

Lobe Sciences Annual Data
Trend Dec16 Dec17 Dec18 Aug19 Aug20 Aug21 Aug22 Aug23 Aug24 Aug25
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 -204.33 -338.00 0.00

Lobe Sciences Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

LOBEF vs VRTX, REGN, ALNY: FCF Margin % Comparison

For the Biotechnology subindustry, Lobe Sciences's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lobe Sciences FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Lobe Sciences's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Lobe Sciences's FCF Margin % falls into.


Lobe Sciences FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Lobe Sciences's FCF Margin for the fiscal year that ended in Aug. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Aug. 2025 )/Revenue (A: Aug. 2025 )
=-1.027/0
= %

Lobe Sciences's FCF Margin for the quarter that ended in Feb. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Feb. 2026 )/Revenue (Q: Feb. 2026 )
=-1.509/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
Lobe Sciences (LOBEF) has a FCF Margin % of 0.00% as of Feb. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Lobe Sciences and its competitors. According to the industry distribution chart, Lobe Sciences ranks #999999 out of 960 companies in the Biotechnology industry.
Is Lobe Sciences' FCF Margin % too high?
Lobe Sciences' current FCF Margin % is 0.00%. Based on the distribution chart, Lobe Sciences ranks #999999 out of 960 companies in the Biotechnology industry, which is in the bottom quartile relative to peers.
How does Lobe Sciences' FCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Lobe Sciences ranks #999999 out of 960 companies for FCF Margin %. This places Lobe Sciences in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Lobe Sciences and its competitors. Lobe Sciences's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lobe Sciences stock overvalued right now?
Lobe Sciences (LOBEF) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Lobe Sciences (LOBEF), the current FCF Margin % is 0.00% as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Lobe Sciences Business Description

Other Exchanges LOBE:GermanyLOBE:Canada
Address 1771 Robson Street, No. 1614, Vancouver, BC, CAN, V6G 3B7
Lobe Sciences Ltd is a biopharmaceutical company focused on using lipid technology that develop therapies for orphan and rare diseases. It commercializes Altemia MF, a medical food intended to address nutritional deficiencies associated with sickle cell disease. Through its subsidiaries, the company also holds a majority interest in the development of Conjugated Psilocin for potential use in neurological and psychiatric indications. The company operates in one reportable segment, being the biopharmaceutical development of new medicines.